Investors

Investors

At present, there are already several authorised drugs in the USA, Canada, different European countries, etc. The WHO has been producing reports for years and warning the UN of the need to reclassify them within the different member countries in order to relax international controls and favour their study.

In the last 20 years, more than 70 phytocannabinoids have been described in Cannabis sativa. Their isolation and determination have demonstrated a very high medicinal capacity of some of them such as THC, CBD, CBG or CBC and although their absolute potential is not known at 100%, today there are numerous scientific studies being carried out on aspects related to muscle relaxation, treatment of anorexia, bronchial asthma, epilepsy, glaucoma, hypertension, muscle spasticity, nausea, vomiting or pain. In the latter case, studies conclude that cannabinoids with analgesic potential can reduce the use of opiates (morphines) and even in some patients their use is completely eliminated, with the improvement in quality of life that this implies for the patient, so the pharmaceutical companies are already adapting to the change.

Do you join Pharma Bio Green?

Conclusion

Planta

Colombia, thanks to its regulation on cultivation and export of cannabis derivatives, has become a supplier of by-products for the international pharmaceutical industry, mainly located in Canada, USA, Israel or Switzerland, countries with regulations that regulate psychoactive processes. As far as non-psychoactive derivatives are concerned, its market is global, being used without limitations in cosmetics or food supplements in many states.

As a conclusion to all the above mentioned, the cannabis derivatives already have a remarkable international market simply with the products marketed and approved so far, but their demand will grow exponentially in the coming years due to the drugs that are in the process of approval and new state or EU regulations.

Pharma Bio Green, with its vertically integrated project, the experience of its multidisciplinary professionals and its licenses obtained so far, has in place programs that integrally value the product from beginning to end, completely managing the processes from seed, cultivation, transformation and export of the derivative.